CI
ABMD

Conning Inc’s Abiomed Inc ABMD Stock Holding History

Conning Inc’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,174
Closed -$291K – 392
2022
Q2 		$291K Sell
1,174
-151
-11% -$40.7K 0.01% 322
2022
Q1 		$439K Sell
1,325
-5
-0.4% -$1.54K 0.01% 276
2021
Q4 		$478K Buy
1,330
+22
+2% +$7.43K 0.01% 261
2021
Q3 		$426K Sell
1,308
-337
-20% -$114K 0.01% 295
2021
Q2 		$513K Sell
1,645
-211
-11% -$64.7K 0.01% 271
2021
Q1 		$592K Sell
1,856
-50
-3% -$16K 0.02% 244
2020
Q4 		$618K Sell
1,906
-15
-0.8% -$4.15K 0.02% 246
2020
Q3 		$532K Buy
1,921
+30
+2% +$8.64K 0.02% 255
2020
Q2 		$457K Buy
1,891
+132
+8% +$26.5K 0.02% 265
2020
Q1 		$255K Buy
1,759
+4
+0.2% +$664 0.01% 350
2019
Q4 		$299K Buy
+1,755
New +$325K 0.01% 391
2019
Q2 		– Sell
-720
Closed -$206K – 527
2019
Q1 		$206K Buy
+720
New +$239K 0.01% 514

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Conning Inc's ABMD Position: Q3 2022 in Review

Conning Inc sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 1,174 shares — an estimated $291K sold.

Conning Inc first reported a position in ABMD in Q1 2019 and held it in 12 quarters. The position peaked at $618K in Q4 2020. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Conning Inc reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Conning Inc sold 1,174 Abiomed Inc shares in Q3 2022, an estimated $291K.
  • Conning Inc first reported a position in Abiomed Inc in Q1 2019 and held it in 12 quarters.
  • Conning Inc's Abiomed Inc position peaked at $618K in Q4 2020.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Conning Inc's 13F filing for Q3 2022, filed 31 Oct 2022.